Citations (102)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Shoshy Mizrahy, Anna Gutkin, Paolo Decuzzi & Dan Peer. (2019) Targeting central nervous system pathologies with nanomedicines. Journal of Drug Targeting 27:5-6, pages 542-554.
Read now
Read now
Mukta Agrawal, Swarnlata Saraf, Shailendra Saraf, Sophia G. Antimisiaris, Nobuhito Hamano, Shyh-Dar Li, Mahavir Chougule, Sunday A. Shoyele, Umesh Gupta, Ajazuddin & Amit Alexander. (2018) Recent advancements in the field of nanotechnology for the delivery of anti-Alzheimer drug in the brain region. Expert Opinion on Drug Delivery 15:6, pages 589-617.
Read now
Read now
Balakumar Krishnamoorthy, Vamshikrishna Karanam, Vijaya Raghavan Chellan, Karthik Siram, Tamil selvan Natarajan & Marslin Gregory. (2014) Polymersomes as an effective drug delivery system for glioma – a review. Journal of Drug Targeting 22:6, pages 469-477.
Read now
Read now
Zhiqing Pang, Huile Gao, Jun Chen, Shun Shen, Bo Zhang, Jinfeng Ren, Liangran Guo, Yong Qian, Xinguo Jiang & Heng Mei. (2012) Intracellular delivery mechanism and brain delivery kinetics of biodegradable cationic bovine serum albumin-conjugated polymersomes. International Journal of Nanomedicine 7, pages 3421-3432.
Read now
Read now
Werner Geldenhuys, Thomas Mbimba, Thong Bui, Kimberly Harrison & Vijaykumar Sutariya. (2011) Brain-targeted delivery of paclitaxel using glutathione-coated nanoparticles for brain cancers. Journal of Drug Targeting 19:9, pages 837-845.
Read now
Read now
Valentino Laquintana, Adriana Trapani, Nunzio Denora, Fan Wang, James M Gallo & Giuseppe Trapani. (2009) New strategies to deliver anticancer drugs to brain tumors. Expert Opinion on Drug Delivery 6:10, pages 1017-1032.
Read now
Read now
Giovanni Tosi, Luca Costantino, Barbara Ruozi, Flavio Forni & Maria Angela Vandelli. (2008) Polymeric nanoparticles for the drug delivery to the central nervous system. Expert Opinion on Drug Delivery 5:2, pages 155-174.
Read now
Read now
Herbert B Newton. (2006) Advances in strategies to improve drug delivery to brain tumors. Expert Review of Neurotherapeutics 6:10, pages 1495-1509.
Read now
Read now
Soumyajit Majumdar & Ashim K Mitra. (2006) Chemical modification and formulation approaches to elevated drug transport across cell membranes. Expert Opinion on Drug Delivery 3:4, pages 511-527.
Read now
Read now
Articles from other publishers (93)
Juliana C.S. Chaves, Samantha J. Dando, Anthony R. White & Lotta E. Oikari. (2024) Blood-brain barrier transporters: An overview of function, dysfunction in Alzheimer's disease and strategies for treatment. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1870:2, pages 166967.
Crossref
Crossref
Thomas Lee Moore, Giovanna Pannuzzo, Gabriella Costabile, Anna Lisa Palange, Raffaele Spanò, Miguel Ferreira, Adriana Carol Eleonora Graziano, Paolo Decuzzi & Venera Cardile. (2023) Nanomedicines to treat rare neurological disorders: The case of Krabbe disease. Advanced Drug Delivery Reviews 203, pages 115132.
Crossref
Crossref
Wilma Delphine Silvia CR, Akshay Atre, Preksha Shivakumar & Arpita Chakraborty. (2023) Mucopolysaccharidosis: An overview and new treatment modalities. International Journal of Clinical Biochemistry and Research 10:2, pages 101-109.
Crossref
Crossref
Ülo LangelÜlo Langel. 2023. CPP, Cell-Penetrating Peptides. CPP, Cell-Penetrating Peptides
219
262
.
Maj Schneider Thomsen, Kasper Bendix Johnsen, Krzysztof Kucharz, Martin Lauritzen & Torben Moos. (2022) Blood–Brain Barrier Transport of Transferrin Receptor-Targeted Nanoparticles. Pharmaceutics 14:10, pages 2237.
Crossref
Crossref
Ju Seung Lee, Jiwon Kim, Yeong-sinn Ye & Tae-il Kim. (2022) Materials and device design for advanced phototherapy systems. Advanced Drug Delivery Reviews 186, pages 114339.
Crossref
Crossref
Reeju Amatya, Kyoung Ah Min & Meong Cheol Shin. (2022) A review of glucoregulatory hormones potentially applicable to the treatment of Alzheimer’s disease: mechanism and brain delivery. Journal of Pharmaceutical Investigation 52:2, pages 195-216.
Crossref
Crossref
Annu, Ali Sartaj, Zufika Qamar, Shadab Md, Nabil A. Alhakamy, Sanjula Baboota & Javed Ali. (2022) An Insight to Brain Targeting Utilizing Polymeric Nanoparticles: Effective Treatment Modalities for Neurological Disorders and Brain Tumor. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Crossref
Ka Hong WongMuhammad Kashif RiazYuning XieXue ZhangQiang Liu, Huoji ChenZhaoxiang BianXiaoyu ChenAiping LuZhijun Yang. (2022) Review of Current Strategies for Delivering Alzheimer's Disease Drugs Across the Blood-Brain Barrier. FOCUS 20:1, pages 117-136.
Crossref
Crossref
Dominique Lesuisse. 2022. Drug Delivery to the Brain. Drug Delivery to the Brain
27
69
.
Nurettin Sezer, İbrahim Arı, Yusuf Biçer & Muammer Koç. (2021) Superparamagnetic nanoarchitectures: Multimodal functionalities and applications. Journal of Magnetism and Magnetic Materials 538, pages 168300.
Crossref
Crossref
Mallesh Kurakula, Shashank Gorityala, Devang B. Patel, Pratap Basim, Bhaumik Patel & Saurabh Kumar Jha. (2021) Trends of Chitosan Based Delivery Systems in Neuroregeneration and Functional Recovery in Spinal Cord Injuries. Polysaccharides 2:2, pages 519-537.
Crossref
Crossref
Anisha D'Souza, Kandarp M. Dave, R. Anne Stetler & Devika S. Manickam. (2021) Targeting the blood-brain barrier for the delivery of stroke therapies. Advanced Drug Delivery Reviews 171, pages 332-351.
Crossref
Crossref
A. Zaghmi, J. Drouin-Ouellet, D. Brambilla & M.A. Gauthier. (2021) Treating brain diseases using systemic parenterally-administered protein therapeutics: Dysfunction of the brain barriers and potential strategies. Biomaterials 269, pages 120461.
Crossref
Crossref
Bohye Chung, Jaehoon Kim, Jiyoung Nam, Hyunho Kim, Yeju Jeong, Hui‐wen Liu, Youngkyu Cho, Yong Ho Kim, Hyun Jeong Oh & Seok Chung. (2020) Evaluation of Cell‐Penetrating Peptides Using Microfluidic In Vitro 3D Brain Endothelial Barrier. Macromolecular Bioscience 20:6.
Crossref
Crossref
Jozef Hanes, Eva Dobakova & Petra Majerova. (2020) Brain Drug Delivery: Overcoming the Blood-brain Barrier to Treat Tauopathies. Current Pharmaceutical Design 26:13, pages 1448-1465.
Crossref
Crossref
Sunil Kumar Dubey, K.K. Lakshmi, Kowthavarapu Venkata Krishna, Mukta Agrawal, Gautam Singhvi, Ranendra Narayana Saha, Swarnlata Saraf, Shailendra Saraf, Rahul Shukla & Amit Alexander. (2020) Insulin mediated novel therapies for the treatment of Alzheimer's disease. Life Sciences 249, pages 117540.
Crossref
Crossref
Ka Wong, Muhammad Riaz, Yuning Xie, Xue Zhang, Qiang Liu, Huoji Chen, Zhaoxiang Bian, Xiaoyu Chen, Aiping Lu & Zhijun Yang. (2019) Review of Current Strategies for Delivering Alzheimer’s Disease Drugs across the Blood-Brain Barrier. International Journal of Molecular Sciences 20:2, pages 381.
Crossref
Crossref
Xiaopeng Mo, Ergang Liu & Yongzhuo Huang. 2019. Brain Targeted Drug Delivery System. Brain Targeted Drug Delivery System
409
438
.
Zui Zhang & Changyou Zhan. 2019. Brain Targeted Drug Delivery System. Brain Targeted Drug Delivery System
105
128
.
Ülo LangelÜlo Langel. 2019. CPP, Cell-Penetrating Peptides. CPP, Cell-Penetrating Peptides
195
263
.
Syed Tazib Rahaman. 2019. Nanobiotechnology in Neurodegenerative Diseases. Nanobiotechnology in Neurodegenerative Diseases
49
63
.
Brian M. Kopec, Kavisha R. Ulapane, Mario E. G. Moral & Teruna J. Siahaan. 2019. Blood-Brain Barrier. Blood-Brain Barrier
9
43
.
Xiaopeng Mo, Zening Zheng, Yang He, Huihai Zhong, Xuejia Kang, Mingjie Shi, Tuanbing Liu, Zheng Jiao & Yongzhuo Huang. (2018) Antiglioma via regulating oxidative stress and remodeling tumor-associated macrophage using lactoferrin-mediated biomimetic codelivery of simvastatin/fenretinide. Journal of Controlled Release 287, pages 12-23.
Crossref
Crossref
Hongchen Hua, Xuemei Zhang, Hongjie Mu, Qingqing Meng, Ying Jiang, Yiyun Wang, Xiaoyan Lu, Aiping Wang, Sha Liu, Yaping Zhang, Zhihui Wan & Kaoxiang Sun. (2018) RVG29-modified docetaxel-loaded nanoparticles for brain-targeted glioma therapy. International Journal of Pharmaceutics 543:1-2, pages 179-189.
Crossref
Crossref
Maurizio Scarpa, Paul J. Orchard, Angela Schulz, Patricia I. Dickson, Mark E. Haskins, Maria L. Escolar & Roberto Giugliani. (2017) Treatment of brain disease in the mucopolysaccharidoses. Molecular Genetics and Metabolism 122, pages 25-34.
Crossref
Crossref
Herren Wu, Carl Webster, Judy Paterson, Sandrine Guillard, Ron Jackson & Ralph Minter. 2017. Protein Therapeutics. Protein Therapeutics
661
700
.
Yung-Chih Kuo & Rajendiran Rajesh. (2017) Targeted delivery of rosmarinic acid across the blood–brain barrier for neuronal rescue using polyacrylamide-chitosan-poly(lactide- co -glycolide) nanoparticles with surface cross-reacting material 197 and apolipoprotein E. International Journal of Pharmaceutics 528:1-2, pages 228-241.
Crossref
Crossref
Per-Ola Freskgård & Eduard Urich. (2017) Antibody therapies in CNS diseases. Neuropharmacology 120, pages 38-55.
Crossref
Crossref
Fei Fang, Dan Zou, Wei Wang, Ying Yin, Tieying Yin, Shilei Hao, Bochu Wang, Guixue Wang & Yazhou Wang. (2017) Non-invasive approaches for drug delivery to the brain based on the receptor mediated transport. Materials Science and Engineering: C 76, pages 1316-1327.
Crossref
Crossref
Alexander V. Kabanov & Elena V. Batrakova. 2017. Neuroimmune Pharmacology. Neuroimmune Pharmacology
847
868
.
Pieter J. Gaillard. (2016) BBB crossing assessment and BBB crossing technologies in CNS Drug Discovery. Drug Discovery Today: Technologies 20, pages 1-3.
Crossref
Crossref
Geert J. Schenk & Helga E. de Vries. (2016) Altered blood–brain barrier transport in neuro-inflammatory disorders. Drug Discovery Today: Technologies 20, pages 5-11.
Crossref
Crossref
B. Milojkovic Kerklaan, O. van Tellingen, A. D. R. Huitema, J. H. Beijnen, W. Boogerd, J. H. M. Schellens & D. Brandsma. (2015) Strategies to target drugs to gliomas and CNS metastases of solid tumors. Journal of Neurology 263:3, pages 428-440.
Crossref
Crossref
G. Fullstone, S. Nyberg, X. Tian & G. Battaglia. 2016. Nanotechnology and the Brain. Nanotechnology and the Brain
41
72
.
John Kealy & Matthew Campbell. 2016. Resistance to Targeted Therapies Against Adult Brain Cancers. Resistance to Targeted Therapies Against Adult Brain Cancers
69
87
.
Kathleen A. Ross, Timothy M. Brenza, Andrea M. Binnebose, Yashdeep Phanse, Anumantha G. Kanthasamy, Howard E. Gendelman, Aliasger K. Salem, Lyric C. Bartholomay, Bryan H. Bellaire & Balaji Narasimhan. (2015) Nano-enabled delivery of diverse payloads across complex biological barriers. Journal of Controlled Release 219, pages 548-559.
Crossref
Crossref
Stephen Meairs. (2015) Facilitation of Drug Transport across the Blood–Brain Barrier with Ultrasound and Microbubbles. Pharmaceutics 7:3, pages 275-293.
Crossref
Crossref
Changyou Zhan, Chong Li, Xiaoli Wei, Wuyuan Lu & Weiyue Lu. (2015) Toxins and derivatives in molecular pharmaceutics: Drug delivery and targeted therapy. Advanced Drug Delivery Reviews 90, pages 101-118.
Crossref
Crossref
Surya K. Mallapragada, Timothy M. Brenza, JoEllyn M. McMillan, Balaji Narasimhan, Donald S. Sakaguchi, Anup D. Sharma, Svitlana Zbarska & Howard E. Gendelman. (2015) Enabling nanomaterial, nanofabrication and cellular technologies for nanoneuromedicines. Nanomedicine: Nanotechnology, Biology and Medicine 11:3, pages 715-729.
Crossref
Crossref
Magdalena Rowinska-Zyrek, Milena Salerno & Henryk Kozlowski. (2015) Neurodegenerative diseases – Understanding their molecular bases and progress in the development of potential treatments. Coordination Chemistry Reviews 284, pages 298-312.
Crossref
Crossref
Morgan Robinson, Brenda Yasie Lee & Zoya Leonenko. (2015) Drugs and drug delivery systems targeting amyloid-β in Alzheimer's disease. AIMS Molecular Science 2:3, pages 332-358.
Crossref
Crossref
Werner Gladdines, Corine C. Visser, Marco de Boer, Chantal C.M. Appeldoorn, Arie Reijerkerk, Jaap Rip & Pieter J. Gaillard. 2015. Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies. Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies
463
482
.
Julia Georgieva, Dick Hoekstra & Inge Zuhorn. (2014) Smuggling Drugs into the Brain: An Overview of Ligands Targeting Transcytosis for Drug Delivery across the Blood–Brain Barrier. Pharmaceutics 6:4, pages 557-583.
Crossref
Crossref
Patricia Campos-Bedolla, Fruzsina R. Walter, Szilvia Veszelka & Mária A. Deli. (2014) Role of the Blood–Brain Barrier in the Nutrition of the Central Nervous System. Archives of Medical Research 45:8, pages 610-638.
Crossref
Crossref
Huile Gao, Shuang Zhang, Shijie Cao, Zhi Yang, Zhiqing Pang & Xinguo Jiang. (2014) Angiopep-2 and Activatable Cell-Penetrating Peptide Dual-Functionalized Nanoparticles for Systemic Glioma-Targeting Delivery. Molecular Pharmaceutics 11:8, pages 2755-2763.
Crossref
Crossref
S.G. Antimisiaris, S. Mourtas, E. Markoutsa, A. Skouras & K. Papadia. 2014. Advanced Healthcare Materials. Advanced Healthcare Materials
87
179
.
Sutapa Barua & Samir Mitragotri. (2014) Challenges associated with penetration of nanoparticles across cell and tissue barriers: A review of current status and future prospects. Nano Today 9:2, pages 223-243.
Crossref
Crossref
Jane E. Preston, N. Joan Abbott & David J. Begley. 2014. Pharmacology of the Blood Brain Barrier: Targeting CNS Disorders. Pharmacology of the Blood Brain Barrier: Targeting CNS Disorders
147
163
.
Ani Balmanoukian & Stuart A. Grossman. 2014. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics
519
539
.
Geert J. Schenk, Gijs Kooij, Arie Reijerkerk & Helga de Vries. 2014. Drug Delivery to the Brain. Drug Delivery to the Brain
573
589
.
Y. Joy Yu & Ryan J. Watts. (2013) Developing Therapeutic Antibodies for Neurodegenerative Disease. Neurotherapeutics 10:3, pages 459-472.
Crossref
Crossref
Bai Lu, Guhan Nagappan, Xiaoming Guan, Pradeep J. Nathan & Paul Wren. (2013) BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases. Nature Reviews Neuroscience 14:6, pages 401-416.
Crossref
Crossref
Hiroyuki Uchino, Kiyoshi Hatakeyama, Saori Morota, Tadashi Tanoue, Takahisa Nishiyama, Daiki Usui, Chisato Taguchi, Morika Suzuki, Magnus J. Hansson & Eskil Elmér. 2013. Brain Edema XV. Brain Edema XV
311
315
.
Stephen Meairs. 2014. The Blood Brain Barrier (BBB). The Blood Brain Barrier (BBB)
143
158
.
G Tosi, B Ruozi, L Badiali, L Bondioli, D Belletti, F Forni & M Vandelli. 2012. Nanotechnology in Health Care. Nanotechnology in Health Care
107
168
.
Zhong Zuo & Vincent H. L. Lee. 2012. Chemical Biology. Chemical Biology
147
164
.
R. Prades, M. Teixidó & E. Giralt. 2012. Nanostructured Biomaterials for Overcoming Biological Barriers. Nanostructured Biomaterials for Overcoming Biological Barriers
364
391
.
Pieter J. Gaillard, Corine C. Visser, Chantal C.M. Appeldoorn & Jaap Rip. (2012) Enhanced brain drug delivery: safely crossing the blood–brain barrier. Drug Discovery Today: Technologies 9:2, pages e155-e160.
Crossref
Crossref
Malgosia M Pakulska, Brian G Ballios & Molly S Shoichet. (2012) Injectable hydrogels for central nervous system therapy. Biomedical Materials 7:2, pages 024101.
Crossref
Crossref
Yung-Chih Kuo & Chiu-Yen Chung. (2012) Transcytosis of CRM197-grafted polybutylcyanoacrylate nanoparticles for delivering zidovudine across human brain-microvascular endothelial cells. Colloids and Surfaces B: Biointerfaces 91, pages 242-249.
Crossref
Crossref
Geert J. Schenk, P.C. Joost Haasnoot, Mireille Centlivre, Nicolas Legrand, Jaap Rip, Albertus G. de Boer & Ben Berkhout. (2012) Efficient CRM197-mediated drug targeting to monocytes. Journal of Controlled Release 158:1, pages 139-147.
Crossref
Crossref
H.A. Santos, L.M. Bimbo, J. Das Neves, B. Sarmento & INEB. 2012. Nanomedicine. Nanomedicine
236
301
.
Maria Luisa Bondì, Roberto Di Gesù & Emanuela Fabiola Craparo. 2012. Nanomedicine - Cancer, Diabetes, and Cardiovascular, Central Nervous System, Pulmonary and Inflammatory Diseases. Nanomedicine - Cancer, Diabetes, and Cardiovascular, Central Nervous System, Pulmonary and Inflammatory Diseases
229
251
.
Supriya D. Mahajan, Wing-Cheung Law, Ravikumar Aalinkeel, Jessica Reynolds, Bindukumar B. Nair, Ken-Tye Yong, Indrajit Roy, Paras N. Prasad & Stanley A. Schwartz. 2012. Nanomedicine - Infectious Diseases, Immunotherapy, Diagnostics, Antifibrotics, Toxicology and Gene Medicine. Nanomedicine - Infectious Diseases, Immunotherapy, Diagnostics, Antifibrotics, Toxicology and Gene Medicine
41
60
.
Sabrina Höbel, Chantal C.M. Appeldoorn, Pieter J. Gaillard & Achim Aigner. (2011) Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in Glioblastoma. Pharmaceuticals 4:12, pages 1591-1606.
Crossref
Crossref
Gregory Russell-Jones. (2011) Intestinal receptor targeting for peptide delivery: an expert’s personal perspective on reasons for failure and new opportunities. Therapeutic Delivery 2:12, pages 1575-1593.
Crossref
Crossref
Gao Huile, Pan Shuaiqi, Yang Zhi, Cao Shijie, Chen Chen, Jiang Xinguo, Shen Shun, Pang Zhiqing & Hu Yu. (2011) A cascade targeting strategy for brain neuroglial cells employing nanoparticles modified with angiopep-2 peptide and EGFP-EGF1 protein. Biomaterials 32:33, pages 8669-8675.
Crossref
Crossref
Ping Wang, Yunhui Liu, Xiuli Shang & Yixue Xue. (2010) CRM197-Induced Blood–Brain Barrier Permeability Increase is Mediated by Upregulation of Caveolin-1 Protein. Journal of Molecular Neuroscience 43:3, pages 485-492.
Crossref
Crossref
Nadia Caram-Salas, Eve Boileau, Graham K. Farrington, Ellen Garber, Eric Brunette, Abedelnasser Abulrob & Danica Stanimirovic. 2011. Permeability Barrier. Permeability Barrier
383
401
.
Umar Iqbal, Abedelnasser Abulrob & Danica B. Stanimirovic. 2011. The Blood-Brain and Other Neural Barriers. The Blood-Brain and Other Neural Barriers
465
481
.
Sylvia Wagner, Jürgen Kufleitner, Anja Zensi, Miriam Dadparvar, Sascha Wien, Judith Bungert, Tikva Vogel, Franz Worek, Jörg Kreuter & Hagen von Briesen. (2010) Nanoparticulate Transport of Oximes over an In Vitro Blood-Brain Barrier Model. PLoS ONE 5:12, pages e14213.
Crossref
Crossref
Yanick Bertrand, Jean‐Christophe Currie, Michel Demeule, Anthony Régina, Christian Ché, Abedelnasser Abulrob, Dorothy Fatehi, Hervé Sartelet, Reinhard Gabathuler, Jean‐Paul Castaigne, Danica Stanimirovic & Richard Béliveau. (2010) Transport characteristics of a novel peptide platform for CNS therapeutics. Journal of Cellular and Molecular Medicine 14:12, pages 2827-2839.
Crossref
Crossref
Pieter J Gaillard. (2010) Crossing barriers from blood-to-brain and academia-to-industry. Therapeutic Delivery 1:4, pages 495-500.
Crossref
Crossref
Ping Wang, Yixue Xue, Xiuli Shang & Yunhui Liu. (2010) Diphtheria Toxin Mutant CRM197-Mediated Transcytosis across Blood–Brain Barrier In Vitro. Cellular and Molecular Neurobiology 30:5, pages 717-725.
Crossref
Crossref
Lamya S. Shihabuddin & Isabelle Aubert. (2010) Stem cell transplantation for neurometabolic and neurodegenerative diseases. Neuropharmacology 58:6, pages 845-854.
Crossref
Crossref
N. Joan Abbott, Adjanie A.K. Patabendige, Diana E.M. Dolman, Siti R. Yusof & David J. Begley. (2010) Structure and function of the blood–brain barrier. Neurobiology of Disease 37:1, pages 13-25.
Crossref
Crossref
Heidrun Potschka. 2010. Drug Delivery. Drug Delivery
411
431
.
David D StenehjemAnika MS Hartz, Björn BauerGrant W Anderson. (2009) Novel and emerging strategies in drug delivery for overcoming the blood–brain barrier. Future Medicinal Chemistry 1:9, pages 1623-1641.
Crossref
Crossref
Yun-Yan Wang, Philip CW Lui & Jian Yi Li. (2009) Receptor-mediated therapeutic transport across the blood–brain barrier. Immunotherapy 1:6, pages 983-993.
Crossref
Crossref
D M McCarty, J DiRosario, K Gulaid, J Muenzer & H Fu. (2009) Mannitol-facilitated CNS entry of rAAV2 vector significantly delayed the neurological disease progression in MPS IIIB mice. Gene Therapy 16:11, pages 1340-1352.
Crossref
Crossref
N. Weiss, F. Miller, S. Cazaubon & P.-O. Couraud. (2009) Biologie de la barrière hématoencéphalique : Partie I. Revue Neurologique 165:11, pages 863-874.
Crossref
Crossref
Angela R. Jones & Eric V. Shusta. 2009. Therapeutic Monoclonal Antibodies. Therapeutic Monoclonal Antibodies
483
502
.
Anja Zensi, David Begley, Charles Pontikis, Celine Legros, Larisa Mihoreanu, Sylvia Wagner, Claudia Büchel, Hagen von Briesen & Jörg Kreuter. (2009) Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones. Journal of Controlled Release 137:1, pages 78-86.
Crossref
Crossref
Daniel Schulze & Achim Aigner. 2009. Therapeutic Ribonucleic Acids in Brain Tumors. Therapeutic Ribonucleic Acids in Brain Tumors
197
220
.
Jaap Rip, Geert J Schenk & Albertus G de Boer. (2008) Drug targeting to the brain. BMC Proceedings 2:S1.
Crossref
Crossref
A Régina, M Demeule, C Ché, I Lavallée, J Poirier, R Gabathuler, R Béliveau & J-P Castaigne. (2008) Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2. British Journal of Pharmacology 155:2, pages 185-197.
Crossref
Crossref
Tadhg P. BegleyZhong Zuo & Vincent H. L. Lee. 2007. Wiley Encyclopedia of Chemical Biology. Wiley Encyclopedia of Chemical Biology
1
10
.
Michel Demeule, Anthony Régina, Christian Ché, Julie Poirier, Tran Nguyen, Reinhard Gabathuler, Jean-Paul Castaigne & Richard Béliveau. (2008) Identification and Design of Peptides as a New Drug Delivery System for the Brain. Journal of Pharmacology and Experimental Therapeutics 324:3, pages 1064-1072.
Crossref
Crossref
Pieter J. Gaillard & Albertus G. de Boer. 2008. Drug Delivery Systems. Drug Delivery Systems
161
175
.
A.V. Kabanov & H.E. Gendelman. (2007) Nanomedicine in the diagnosis and therapy of neurodegenerative disorders. Progress in Polymer Science 32:8-9, pages 1054-1082.
Crossref
Crossref
Angela R. Jones & Eric V. Shusta. (2007) Blood–Brain Barrier Transport of Therapeutics via Receptor-Mediation. Pharmaceutical Research 24:9, pages 1759-1771.
Crossref
Crossref
Adam A. Golabek & Elizabeth Kida. (2006) Tripeptidyl-peptidase I in health and disease. Biological Chemistry 387:8, pages 1091-1099.
Crossref
Crossref